Aastrom Maps Out Pivotal Trial Strategy With Adult Stem Cell Therapy

Biotech is one of the most regulated businesses on the planet, so it’s clear that if Aastrom Biosciences is going to get anywhere, it had better have a good strategy for working with U.S. drug regulators.
Xconomy